Literature DB >> 30328585

Low-Grade Inflammation Aggravates Rotenone Neurotoxicity and Disrupts Circadian Clock Gene Expression in Rats.

Huan Li1,2, Sheng Song3, Yuan Wang1, Chun Huang1, Feng Zhang1, Jie Liu4,5, Jau-Shyong Hong3.   

Abstract

A single injection of LPS produced low-grade neuroinflammation leading to Parkinson's disease (PD) in mice several months later. Whether such a phenomenon occurs in rats and whether such low-grade neuroinflammation would aggravate rotenone (ROT) neurotoxicity and disrupts circadian clock gene/protein expressions were examined in this study. Male rats were given two injections of LPS (2.5-7.5 mg/kg), and neuroinflammation and dopamine neuron loss were evident 3 months later. Seven months after a single LPS (5 mg/kg) injection, rats received low doses of ROT (0.5 mg/kg, sc, 5 times/week for 4 weeks) to examine low-grade neuroinflammation on ROT toxicity. LPS plus ROT produced more pronounced non-motor and motor dysfunctions than LPS or ROT alone in behavioral tests, and decreased mitochondrial complex 1 activity, together with aggravated neuroinflammation and neuron loss. The expressions of clock core genes brain and muscle Arnt-like protein-1 (Bmal1), locomotor output cycles kaput (Clock), and neuronal PAS domain protein-2 (Npas2) were decreased in LPS, ROT, and LPS plus ROT groups. The expressions of circadian feedback genes Periods (Per1 and Per2) were also decreased, but Cryptochromes (Cry1 and Cry2) were unaltered. The circadian clock target genes nuclear receptor Rev-Erbα (Nr1d1), and D-box-binding protein (Dbp) expressions were also decreased. Consistent with the transcript levels, circadian clock protein BMAL1, CLOCK, NR1D1, and DBP were also decreased. Thus, LPS-induced chronic low-grade neuroinflammation potentiated ROT neurotoxicity and disrupted circadian clock gene/protein expression, suggesting a role of disrupted circadian in PD development and progression. Graphical Abstract ᅟ.

Entities:  

Keywords:  Circadian clock gene expression; Lipopolysaccharide; Neurotoxicity; Non-motor dysfunction; Parkinson’s disease; Rotenone

Mesh:

Substances:

Year:  2018        PMID: 30328585      PMCID: PMC6543539          DOI: 10.1007/s12640-018-9968-1

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  55 in total

1.  Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration.

Authors:  Liya Qin; Xuefei Wu; Michelle L Block; Yuxin Liu; George R Breese; Jau-Shyong Hong; Darin J Knapp; Fulton T Crews
Journal:  Glia       Date:  2007-04-01       Impact factor: 7.452

Review 2.  Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.

Authors:  Hui-Ming Gao; Jau-Shyong Hong
Journal:  Trends Immunol       Date:  2008-07-01       Impact factor: 16.687

3.  Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits.

Authors:  Yuxin Liu; Liya Qin; Belinda Wilson; Xuefei Wu; Li Qian; Ann-Charlotte Granholm; Fulton T Crews; Jau-Shyong Hong
Journal:  Neurotoxicology       Date:  2008-03-13       Impact factor: 4.294

Review 4.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms.

Authors:  Michelle L Block; Luigi Zecca; Jau-Shyong Hong
Journal:  Nat Rev Neurosci       Date:  2007-01       Impact factor: 34.870

5.  Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease.

Authors:  Hui-Ming Gao; Jau-Shyong Hong; Wanqin Zhang; Bin Liu
Journal:  J Neurosci       Date:  2003-02-15       Impact factor: 6.167

6.  Systemic lipopolysaccharide plus MPTP as a model of dopamine loss and gait instability in C57Bl/6J mice.

Authors:  Stefanie L Byler; Gary W Boehm; Jonathan D Karp; Rachel A Kohman; Andrew J Tarr; Timothy Schallert; Timothy M Barth
Journal:  Behav Brain Res       Date:  2008-11-25       Impact factor: 3.332

7.  Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease.

Authors:  M T Tadaiesky; P A Dombrowski; C P Figueiredo; E Cargnin-Ferreira; C Da Cunha; R N Takahashi
Journal:  Neuroscience       Date:  2008-09-09       Impact factor: 3.590

Review 8.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

Review 9.  Pesticides and Parkinson's disease--is there a link?

Authors:  Terry P Brown; Paul C Rumsby; Alexander C Capleton; Lesley Rushton; Leonard S Levy
Journal:  Environ Health Perspect       Date:  2006-02       Impact factor: 9.031

10.  Elevated plus maze for mice.

Authors:  Munekazu Komada; Keizo Takao; Tsuyoshi Miyakawa
Journal:  J Vis Exp       Date:  2008-12-22       Impact factor: 1.355

View more
  5 in total

Review 1.  Importance of Bmal1 in Alzheimer's disease and associated aging-related diseases: Mechanisms and interventions.

Authors:  Rongping Fan; Xuemin Peng; Lei Xie; Kun Dong; Delin Ma; Weijie Xu; Xiaoli Shi; Shujun Zhang; Juan Chen; Xuefeng Yu; Yan Yang
Journal:  Aging Cell       Date:  2022-09-03       Impact factor: 11.005

2.  Altered Motor Performance, Sleep EEG, and Parkinson's Disease Pathology Induced by Chronic Sleep Deprivation in Lrrk2G2019S Mice.

Authors:  Xinyao Liu; Hang Yu; Yuanyuan Wang; Song Li; Cheng Cheng; Murad Al-Nusaif; Weidong Le
Journal:  Neurosci Bull       Date:  2022-05-25       Impact factor: 5.271

Review 3.  Sleep and circadian rhythms in Parkinson's disease and preclinical models.

Authors:  Jeremy Hunt; Elizabeth J Coulson; Rajendram Rajnarayanan; Henrik Oster; Aleksandar Videnovic; Oliver Rawashdeh
Journal:  Mol Neurodegener       Date:  2022-01-09       Impact factor: 14.195

Review 4.  NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson's Disease.

Authors:  William M Curtis; William A Seeds; Mark P Mattson; Patrick C Bradshaw
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

5.  Chronic Manganese Administration with Longer Intervals Between Injections Produced Neurotoxicity and Hepatotoxicity in Rats.

Authors:  Xi-Min Fan; Ying Luo; Yu-Ming Cao; Ting-Wang Xiong; Sheng Song; Jie Liu; Qi-Yuan Fan
Journal:  Neurochem Res       Date:  2020-06-02       Impact factor: 3.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.